AU5970699A - Use - Google Patents

Use

Info

Publication number
AU5970699A
AU5970699A AU59706/99A AU5970699A AU5970699A AU 5970699 A AU5970699 A AU 5970699A AU 59706/99 A AU59706/99 A AU 59706/99A AU 5970699 A AU5970699 A AU 5970699A AU 5970699 A AU5970699 A AU 5970699A
Authority
AU
Australia
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU59706/99A
Inventor
Carol Routledge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of AU5970699A publication Critical patent/AU5970699A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
AU59706/99A 1998-08-28 1999-08-25 Use Abandoned AU5970699A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9818914 1998-08-28
GBGB9818914.5A GB9818914D0 (en) 1998-08-28 1998-08-28 Use
PCT/EP1999/006219 WO2000012623A2 (en) 1998-08-28 1999-08-25 Use of 5-th receptor antagonists for the treatment of parkinson's disease

Publications (1)

Publication Number Publication Date
AU5970699A true AU5970699A (en) 2000-03-21

Family

ID=10838073

Family Applications (1)

Application Number Title Priority Date Filing Date
AU59706/99A Abandoned AU5970699A (en) 1998-08-28 1999-08-25 Use

Country Status (3)

Country Link
AU (1) AU5970699A (en)
GB (1) GB9818914D0 (en)
WO (1) WO2000012623A2 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7041691B1 (en) 1999-06-30 2006-05-09 Amgen Inc. Compounds for the modulation of PPARγ activity
US6586592B2 (en) 2000-06-20 2003-07-01 Pharmacia & Upjohn Company Bis-arylsulfones
PE20020063A1 (en) 2000-06-20 2002-01-30 Upjohn Co BIS-ARYLSULFONES AS LIGANDS OF THE 5-HT RECEPTOR
AU2001288053A1 (en) * 2000-09-18 2002-03-26 Toa Eiyo Ltd. N-substituted benzothiophenesulfonamide derivatives
US7071220B2 (en) 2000-09-18 2006-07-04 Toa Eiyo Ltd. N-substituted benzothiophenesulfonamide derivatives
WO2002055012A2 (en) 2001-01-16 2002-07-18 Astrazeneca Ab Therapeutic heterocyclic compounds
EP1353914A2 (en) 2001-01-16 2003-10-22 AstraZeneca AB Therapeutic chromone compounds
BR0209558A (en) * 2001-05-11 2004-04-20 Biovitrum Ab New Arylsulfonamide Compounds for the Treatment of Obesity, Type II Diabetes, and Snc Disorders
US7718650B2 (en) 2001-05-11 2010-05-18 Biovitrum Ab Aryl sulfonamide compounds for treating obesity
EP1423106B1 (en) 2001-08-10 2008-12-17 F. Hoffmann-La Roche Ag Arylsulfonyl derivatives with 5-ht 6 receptor affinity
WO2003078419A1 (en) * 2002-03-15 2003-09-25 Toa Eiyo Ltd. N-substituted benzothiophenesulfonamide derivative
PA8802201A1 (en) 2007-11-02 2009-06-23 Abbott Gmbh & Co Kg APPROPRIATE BENCENSULFONALIDE COMPOUNDS TO TREAT DISORDERS THAT RESPOND TO THE MODULATION OF SEROTONINE 5-HT6 RECEPTOR
PT2349263E (en) 2008-10-23 2014-07-28 Vertex Pharma Modulators of cystic fibrosis transmembrane conductance regulator
ES2536779T3 (en) 2009-04-30 2015-05-28 Abbvie Deutschland Gmbh & Co Kg N-Phenyl- (piperazinyl or homopiperazinyl) -benzenesulfonamide or benzenesulfonyl-phenyl- (piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
US8183237B2 (en) 2009-04-30 2012-05-22 Abbott Laboratories Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
CN102459199A (en) 2009-04-30 2012-05-16 雅培股份有限两合公司 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
US8343959B2 (en) 2009-04-30 2013-01-01 Abbott Gmbh & Co. Kg N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
WO2012059431A1 (en) 2010-11-01 2012-05-10 Abbott Gmbh & Co. Kg Benzenesulfonyl or sulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-ht6 receptor
WO2012059432A1 (en) 2010-11-01 2012-05-10 Abbott Gmbh & Co. Kg N-phenyl-(homo)piperazinyl-benzenesulfonyl or benzenesulfonamide compounds suitable for treating disorders that respond to the modulation of the 5-ht6 receptor
CA2928537A1 (en) * 2013-10-25 2015-04-30 Glaxosmithkline Llc Novel compounds
BR112017026928B1 (en) * 2016-04-26 2023-04-11 H. Lundbeck A/S USE OF IDALOPYRDINE IN COMBINATION WITH AN ACETYLCHOLINESTERASE INHIBTOR

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9119932D0 (en) * 1991-09-18 1991-10-30 Glaxo Group Ltd Chemical compounds
US5939451A (en) * 1996-06-28 1999-08-17 Hoffmann-La Roche Inc. Use of sulfonamides
DZ2376A1 (en) * 1996-12-19 2002-12-28 Smithkline Beecham Plc New sulfonamide derivatives process for their preparation and pharmaceutical compositions containing them.
EP0994862B1 (en) * 1997-07-11 2005-06-01 SmithKline Beecham plc Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation
GB9801392D0 (en) * 1998-01-22 1998-03-18 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
GB9818914D0 (en) 1998-10-21
WO2000012623A3 (en) 2000-08-24
WO2000012623A2 (en) 2000-03-09

Similar Documents

Publication Publication Date Title
AU3485999A (en) Neo-tryptophan
AU9392998A (en) Pack-a-pillow
AU5970699A (en) Use
AU3522399A (en) Carvedilol-galenics
AU3437799A (en) City-car
AUPP584198A0 (en) New use
AU5407599A (en) Sphingolipid-desaturase
AU3253699A (en) Myxochelines
AU8363398A (en) Capotasto
AU2609599A (en) Sensor-coupling
AU2069199A (en) Codelets
AU3204999A (en) Futureball
AU6235799A (en) New use
AU1055399A (en) Rollerboard
AU5223199A (en) Bathtub-bathseat
AU9347498A (en) Imidazotriazolopyrimidines
AU3347599A (en) Aeromobile
AU3819799A (en) Methoximinomethyloxathiazines
AU2840799A (en) 1-phosphanorbornadienes
AU4813399A (en) New use
AU4768799A (en) Bookcover
AU9218098A (en) Exocyclic-phosphoethanolamines
AU1779099A (en) Heterocyclyl-derivatives
AU3056399A (en) New use
AU4812199A (en) New use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase